| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |